SE8302329L - T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar - Google Patents

T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar

Info

Publication number
SE8302329L
SE8302329L SE8302329A SE8302329A SE8302329L SE 8302329 L SE8302329 L SE 8302329L SE 8302329 A SE8302329 A SE 8302329A SE 8302329 A SE8302329 A SE 8302329A SE 8302329 L SE8302329 L SE 8302329L
Authority
SE
Sweden
Prior art keywords
antigens
preparation
adult
cell
cell leukemia
Prior art date
Application number
SE8302329A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8302329D0 (sv
Inventor
I Mori
K Imagawa
T Seito
M Adachi
Y Hinuma
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8302329D0 publication Critical patent/SE8302329D0/xx
Publication of SE8302329L publication Critical patent/SE8302329L/

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
SE8302329A 1982-04-26 1983-04-25 T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar SE8302329L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57071080A JPS58187861A (ja) 1982-04-26 1982-04-26 成人型ｔ細胞性白血病関連抗体の測定法

Publications (2)

Publication Number Publication Date
SE8302329D0 SE8302329D0 (sv) 1983-04-25
SE8302329L true SE8302329L (sv) 1983-10-27

Family

ID=13450182

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8302329A SE8302329L (sv) 1982-04-26 1983-04-25 T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar

Country Status (13)

Country Link
JP (1) JPS58187861A (de)
BE (1) BE896571A (de)
CA (1) CA1197776A (de)
CH (1) CH652033A5 (de)
DE (1) DE3315081A1 (de)
DK (1) DK181883A (de)
ES (1) ES8501530A1 (de)
FR (1) FR2525475B1 (de)
GB (1) GB2122343B (de)
IT (1) IT1197633B (de)
NL (1) NL8301464A (de)
PH (1) PH19194A (de)
SE (1) SE8302329L (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5962527A (ja) * 1982-09-30 1984-04-10 Eisai Co Ltd 成人ｔ細胞白血病関連抗原の製造方法
JPS59151885A (ja) * 1983-02-18 1984-08-30 Eisai Co Ltd 成人ｔ細胞白血病関連細胞株
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus
JPS6044870A (ja) * 1983-08-22 1985-03-11 Fujirebio Inc 成人ｔ細胞白血病ウイルス抗体検出用試薬
JPS60249058A (ja) * 1984-05-25 1985-12-09 Eisai Co Ltd Ａｔｌウイルス抗体の測定方法および試薬
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
JP2525054B2 (ja) * 1989-08-01 1996-08-14 株式会社トクヤマ 成人ｔ細胞白血病ウィルス感染診断薬
EP2450562B1 (de) 2010-11-09 2015-06-24 Openhydro IP Limited Bergungssystem für eine hydroelektrische Turbine und Bergungsverfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
GB2016687B (en) * 1978-03-20 1982-09-08 Abbott Lab Sugar coated reagents for solid phase immunoassay
FR2435715A1 (fr) * 1979-01-31 1980-04-04 Sanyo Chemical Ind Ltd Nouveaux produits conjugues substance a activite immunologique-verre
CA1148859A (en) * 1979-06-14 1983-06-28 Lacy R. Overby Simultaneous assay of two hepatitis viruses using a solid phase
DE3005495C2 (de) * 1980-02-14 1983-03-31 Institut Pasteur, 75724 Paris Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen

Also Published As

Publication number Publication date
CA1197776A (en) 1985-12-10
GB2122343A (en) 1984-01-11
DE3315081A1 (de) 1983-11-03
JPH0143908B2 (de) 1989-09-25
DK181883D0 (da) 1983-04-25
BE896571A (fr) 1983-10-26
IT8348154A0 (it) 1983-04-26
FR2525475A1 (fr) 1983-10-28
SE8302329D0 (sv) 1983-04-25
FR2525475B1 (fr) 1985-10-31
JPS58187861A (ja) 1983-11-02
GB8311373D0 (en) 1983-06-02
ES522186A0 (es) 1984-12-01
PH19194A (en) 1986-01-28
GB2122343B (en) 1985-09-04
CH652033A5 (fr) 1985-10-31
IT1197633B (it) 1988-12-06
ES8501530A1 (es) 1984-12-01
DK181883A (da) 1983-10-27
NL8301464A (nl) 1983-11-16

Similar Documents

Publication Publication Date Title
SE8200978L (sv) Forfarande och medel for immunologisk analys
ATE1614T1 (de) Immunologisches bestimmungsverfahren.
AU600466B2 (en) Htlv-iii envelope peptides
ATE98700T1 (de) Anti-fr-900506-stoffe-antikoerper und hoechstempfindliches enzym-immunoassay-verfahren.
SE7900661L (sv) Forfarande och reagens for immunoanalys
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
SG78890G (en) Fluorescence screening for blood typing
AU3386089A (en) Polypeptide-induced monoclonal antibodies to oncoproteins
AU5948090A (en) Silver enhanced gold-labelled immuno assay method
AU8317482A (en) Assay of antibodies to soluble antigens
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
SE8302329L (sv) T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar
KR890006812A (ko) 메탐페타민에 대한 모노클로날 항체 그 모노클로날 항체의 제법 메탐페타민의 분석법 및 분석키트
SE8304190D0 (sv) Forfarande och reagens for immunologiska metningar
EP0267622A3 (de) Verfahren zum Nachweis von Antikörper gegen Anti-Adult-T-Zellen-Leukämie-Virus
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
SE8101404L (sv) Reagens och sett for bestemning av aldolas av human-muskeltyp
MY137138A (en) Diagnostic reagents and preparing methods thereof
JPH063358A (ja) 免疫分析用試薬
FI843562L (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
JPS6486066A (en) Reagent for immunological analysis
SE8702829D0 (sv) Komplex for kvalitativ och kvantitativ analys av antigener, antikroppar och/eller mikroorganismer samt forfarande for framstellning derav och anvendning derav

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8302329-1

Effective date: 19881105